Hernández-Romieu AC, Elnecavé-Olaiz A, Huerta-Uribe N, Reynoso-Noverón N

Language: Spanish
References: 29
Page: 34-39
PDF size: 214.31 Kb.

ABSTRACT

Objective. Determine the influence of nutritional counseling, exercise, access to social healthcare and drugs, and the quality of medical care on the control of diabetics. Material and Methods. The information and blood samples were obtained in 2005. Glycemic control was defined as good if HbA1c was ≤7.0%, poor from 7.01% - 9.50% and very poor if HbA1c ›9.5%. Binary logistic regression models were used to determine the association of these factors with HbA1c›9.5%. Results. Thirty percent of the patients with a medical diagnosis of diabetes had adequate metabolic control. Conclusions. Nutritional guidance was associated with an increase in the degree of control. A majority of diabetics have poor or very poor glycemic control. Strengthening the quality of and access to medical care for these patients is urgently needed.

REFERENCES

1. Secretaría de Salud. Mortalidad, 2002. México: SSA, 2002.

2. Secretaría de Salud. Anuario Estadístico. 2002. México: SSA, 2002.

3. Secretaría de Salud. Salud: México 2003. Información para la rendición de cuentas. México: SSA, 2004.

4. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999;159:1873-1880.

5. Secretaría de Salud. Información para la rendición de cuentas. México: SSA, 2004.

6. Secretaría de Salud. Dirección General de Epidemiología, anuarios de Morbilidad. México: SSA, 2004.

7. Lozano-Ascencio R, Frenk-Mora J, González-Block MA. El peso de la enfermedad en adultos mayores. Salud Publica Mex 1996; 38: 419-429.

8. Arredondo A, Zuñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries. The Mexican case. Diabetes Care 2004;27(1):104-109.

9. Instituto Nacional de Salud Pública. Evaluación externa del Programa Oportunidades. México: INSP, 2004:209-245.

10. Secretaría de Salud. Norma Oficial Mexicana NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes. México: SS, 1999.

11. Grupo de Estudio de la Diabetes en Atención Primaria de la Sociedad Catalana de Medicina Familiar y Comunitaria. Diabetes mellitus tipo 2: protocolo de actuación. FMC 2000; 7 (Supl 6):1-54.

12. Secretaría de Salud Norma Oficial Mexicana NOM-015-SSA2-1994, para la prevención, tratamiento y control de la diabetes. Punto 11.11.1.3. México: SSA, 1999.

13. Nathan DM, Buse JB, Davidson MB, et al. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Diabetes Care 2009; 32:193-203.

14. American Diabetes Association. Standards of medical care in diabetes -- 2009. Diabetes Care 2009;32:S13-S61.

15. Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, et al. Utility of HbA1c levels for diabetes case finding in hospitalizaed patients with hyperglycemia. Diabetes Care 2003;26(4):1064-1068.

16. Rohlfing CL, Wiedmeyer H, Little R, England J, Tennill A, Goldtein D. Defining the relationship between plasma glucose and HbA1c. Diabetes Care 2002; 25(2):275-278.

17. Gómez-López V, García-de León S, López C. Control de la diabetes mellitus tipo 2. El índice de hiperglicemia como indicador. Rev Med IMSS 2002; 40 (4): 281-284. [Consultado en diciembre 3 de 2008]. Disponible en: www.imss.gob.mx/NR/rdonlyres/9ED79478-352C-4F0F-9F27-4D766328973F/0/hiperglucemia10.pdf

18. El-Kebbi IM, Ziemer D, Cook CB, Miller ChD, Gallina D, Phillips LD. Comorbidity and glycemic control in patients with type 2 diabetes. Arch Intern Med 2001;161(10):1295-1300.

19. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patient is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125-1136.

20. Henricsson M, Nystrom L, Blohme G, Östman J, Kullberg C, Svensson M, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes. Diabetes Care 2003;26:349-354

21. Jenkins D, Kendall C, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, et al. Effect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes. JAMA, 2008;300(23): 2742-2753.

22. King G, Gakidou E, Ravishankar N, Moore RT, Lakin J, Vargas M, et al. A ‘Politically Robust’ Experimental Design for Public Policy Evaluation, with Application to the Mexican Universal Health Insurance Program. Journal of Policy Analysis and Management 2007;26(3):479–506. [Consultado diciembre 26, 208] Disponible en: http://gking.harvard.edu/files/abs/spd-abs.shtml

23. Aguilar-Salinas CA, Velazquez-Monroy O, Gómez-Pérez FJ, Gonzalez Chávez AG, Esqueda AL, Molina Cuevas V, et al. Characteristics of patients with type 2 diabetes in México. Diabetes Care 2003;26(7):2021-2026.

24. Gudbjornsttir S, Cederholm J, Nilsson PM, Eliasson B. An implementation of the St. Vincent Declaration for quality improvement in diabetes care. Diabetes Care 2003;26:1270-1276.

25. 25.Coon P, Zulkowski K. Adherence to American Diabetes Association Standards of Care by rural health providers Diabetes Care 2002; 25:2224-2229.

26. Ruelas GV, Roybal M, Lu Y, Goldman D, Peters A. Clinical and Behavioral Correlates of Achieving and Maintaining Glycemic Targets in an Underserved Population With Type 2 Diabetes. Diabetes Care 2009:32:54-56.

27. Nettleton JA, Steffen L, Ni H, Liu K, Jacobs DR Jr. Dietary Patterns and Risk of Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2008; 31:1777-1782.

28. Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C. Physical activity/Exercise and type-2 diabetes. Diabetes Care 2004;27:2518-2539.

29. Mainous AG, Diaz VA, Saxena S, Baker R, Everett CJ, Koopman RJ, et al. Diabetes management in the USA and England: comparative analysis of national surveys. J R Soc Med 2006;99: 463-469.